4 ms·
VAED has occurred repeatedly in mRNA vaccine trials, as well as attempts to develop a coronavirus vaccine because the vaccines provide incomplete protection, in
by defaultprimate 5y ago
VAED has occurred repeatedly in mRNA vaccine trials, as well as attempts to develop a coronavirus vaccine because the vaccines provide incomplete protection, in much the same way the current COVID vaccines. It's a primary factor in why they have not made it to market for so long.
https://link.springer.com/article/10.1007/s40259-021-00495-6 https://link.springer.com/article/10.1007/s40259-021-00495-6
https://mvec.mcri.edu.au/references/vaccine-associated-enhanced-disease-vaed/ https://mvec.mcri.edu.au/references/vaccine-associated-enhan...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901381/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901381/
https://pubmed.ncbi.nlm.nih.gov/34384810/ https://pubmed.ncbi.nlm.nih.gov/34384810/
https://www.chop.edu/centers-programs/vaccine-education-center/vaccine-safety/antibody-dependent-enhancement-and-vaccines https://www.chop.edu/centers-programs/vaccine-education-cent...
- epgui 5y agoNo, lol. I would strongly suggest you stop talking about things you know nothing about. - The first 3 links have nothing to do with RNA vaccines - The fourth link says "the ability of SARS-CoV-2 antibodies to mediate infection enhancement in vivo has never been formally demonstrated", and "the results obtained so far have been rather reassuring", which is in agreement with what I said and in direct contradiction with your point. - The fifth link doesn't suggest in any way that VAED is a concern with mRNA vaccines. In fact it says: "Any vaccine that has been found to cause ADE has stopped being used or, more recently as described below for dengue vaccine, been recommended only for those who will not be affected by ADE. Evidence of ADE has not emerged for COVID-19 vaccines even though concerns have been raised."
- defaultprimate 5y agoCool, check back in with me in 9 months